Diroximel Fumarate and Kisqali (400 MG Dose)
Determining the interaction of Diroximel Fumarate and Kisqali (400 MG Dose) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: The use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents may increase the risk of infections. Both diroximel fumarate and dimethyl fumarate alone may cause lymphopenia and serious infections, and the risk may theoretically be increased due to additive immune system effects in the presence of other myelo- or immunosuppressive therapies. MANAGEMENT: The safety and efficacy of diroximel fumarate or dimethyl fumarate in combination with other immunosuppressive agents have not been evaluated. Until further information is available, the use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents should be avoided. References "Product Information. Vumerity (diroximel fumarate)." Alkermes, Inc, Cambridge, MA.
Professional:GENERALLY AVOID: The use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents may increase the risk of infections. Both diroximel fumarate and dimethyl fumarate alone may cause lymphopenia and serious infections, and the risk may theoretically be increased due to additive immune system effects in the presence of other myelo- or immunosuppressive therapies.
MANAGEMENT: The safety and efficacy of diroximel fumarate or dimethyl fumarate in combination with other immunosuppressive agents have not been evaluated. Until further information is available, the use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents should be avoided.
- "Product Information. Vumerity (diroximel fumarate)." Alkermes, Inc, Cambridge, MA.
Generic Name: diroximel fumarate
Brand name:
Synonyms: n.a.
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Diroximel Fumarate-Kisqali (600 MG Dose)
- Diroximel Fumarate-Kisqali Femara Co-Pack
- Diroximel Fumarate-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Diroximel Fumarate-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Diroximel Fumarate-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Diroximel Fumarate-Kitabis Pak
- Kisqali (400 MG Dose)-Disalcid
- Kisqali (400 MG Dose)-Diskets
- Kisqali (400 MG Dose)-Diskets Dispersible
- Kisqali (400 MG Dose)-Disney Cars Gummies
- Kisqali (400 MG Dose)-Disney Princess Gummies
- Kisqali (400 MG Dose)-Disopyramide